Clinical Education Series

Enhance your clinical expertise with NHIA's Clinical Connect + Clinical Edge Webinars, designed for pharmacists, nurses, and other infusion professionals. Each session delivers focused, evidence-based education on key therapies, emerging clinical trends, and best practices in patient management across the home and alternate-site infusion setting. Learners will gain practical insights, strengthen clinical decision-making skills, and stay current with evolving standards of care—all through engaging, accessible online sessions.

  • SCIG in Focus: Equipping Clinicians for CIDP Care
  • Tysabri & MS Care: Safety, Standards, and Clinical Insight
  • Productivity with Purpose: Elevating Clinical Efficiency in Home Infusion
  • Close Call, Clear Insight: Strengthening Safety Through Near Misses & LASA Awareness
  • PN Precision: Assessing, Collaborating & Weaning for Safer Nutrition Transition
  • Style, Service, & Spark: Elevating Communicating and Connection at Work

 

Search by Category
Search by Format
Sort By
Search by Keyword
  • Contains 9 Component(s), Includes Credits Recorded On: 01/15/2026

    This three-part series equips professionals with foundational knowledge and practical insight into SCIG therapy for patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). From standardized supplies to treatment protocols and a real-world case study, participants will gain the tools to support safe, informed, and patient-centered care.

    Clinical Edge: Standardized Supplies for SCIG Patients

    This session will provide professionals with an overview of standardized supplies commonly used with SCIG patients.

    1. Describe patient-specific characteristics used to guide product selection and, therefore, also SCIG supply selection.
    2. Discuss patient assessment findings and how to integrate them into SCIG administration practices.
    3. Review the importance of education and strategies for training.
    4. Recognize the importance of multi-disciplinary collaboration, communication, and shared decision-making to optimize SCIG patient outcomes.

    Clinical Connect: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    This session will provide professionals with an overview of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and the infusion therapies prescribed for treatment.

    1. Describe the pathophysiology, typical clinical features, and initial diagnostic workup for CIDP, and outline treatment options.
    2. Examine the current efficacy, safety, dosing, and administration of therapies for chronic inflammatory demyelinating polyneuropathy (CIDP).
    3. Analyze best practices for the formulation transition of intravenous to subcutaneous immunoglobulin (IVIG to SCIG) among patients with CIDP.
    4. Identify the role of specialty pharmacists in monitoring therapy, optimizing the management of patients, and how collaborating with the interdisciplinary team fosters continuity and safety in patient care and outcomes. 

    Clinical Edge: A Case Study: Examining a Patient with CIDP on SCIG

    This session will provide professionals with an immersive case study experience on a CIDP patient receiving SCIG.

    1. Explain which CIDP patients are ideal candidates for SCIG therapy and important considerations to evaluate when switching from IVIG to SCIG therapy.
    2. Discuss current SCIG efficacy and safety information, dosing, and administration for CIDP and how real-world data may differ.
    3. Improve patient outcomes in CIDP by identifying risk factors and addressing challenges with SCIG therapy.

    NHIA General CE Information

    Leslie Myers, PharmD, IgCP

    Leslie Myers, PharmD, IgCP

    Integrated Clinical Manager

    CSI Pharmacy

    Dr. Leslie Myers, PharmD, IgCP has a wealth of experience in the field of immunoglobulin therapies with a strong background as a clinical pharmacist within the realm of specialty home infusion. Her dedication to enhance patients’ lives requiring clinical intervention through specialty medications aligns perfectly with the culture at CSI. She earned her Doctor of Pharmacy degree from Campbell University in 2008, graduating summa cum laude. Leslie was the founding president of the Women’s Integration Network within AMCP and also enjoys working with Immunoglobulin National Society (IgNS) through multiple committee roles and development of national Ig Therapy Standards of Practice.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Leslie Myers has no relevant financial relationships with ineligible companies to disclose.

  • Contains 9 Component(s), Includes Credits Recorded On: 03/18/2026

    This three-part series equips healthcare professionals with essential knowledge for safely managing patients with Multiple Sclerosis receiving Tysabri. From understanding the REMS program and IV treatment options to recognizing post-infusion risks and reporting adverse events, participants will gain the tools to deliver informed, compliant, and patient-centered care.

    Clinical Edge: REMS Program: What is it & Why Does it Matter

    This session will provide professionals with an overview of the REMS program and how it applies to patients receiving Tysabri.

    1. Describe the natalizumab REMS program and its purpose.
    2. Discuss the role of the REMS program in promoting patient safety for high-risk medications like natalizumab.
    3. Explain key responsibilities of health care professionals within the REMS program.

    Clinical Connect: Multiple Sclerosis

    This session will provide professionals with an overview of Multiple Sclerosis and the IV medications prescribed for treatment.

    1. Describe the pathophysiology and clinical presentation of Multiple Sclerosis.
    2. Discuss the role and mechanisms of IV therapy indicated to treat Multiple Sclerosis.
    3. Explain key clinical considerations and patient education points for infusion-based MS treatments.

    Clinical Edge: Post Monitoring ADR Reporting

    This session will provide professionals with an overview of the key indicators for post monitoring and how to report adverse drug reactions related to patients receiving Tysabri.

    1. Describe the purpose and process of post-infusion monitoring for patients on Tysabri.
    2. Discuss common and serious adverse drug reactions associated with Tysabri.
    3. Explain the appropriate steps for documenting and reporting ADRs per protocol and REMS requirements.

    NHIA General CE Information

    Jordan Bruns

    Jordan Bruns

    Clinical Programs Manager

    CSI Pharmacy

    Jordan is a specialty and home infusion pharmacist with more than 10 years of experience in the home infusion space with a focus on immunoglobulin and biologic therapies.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

     Jordan Bruns has no relevant financial relationships with ineligible companies to disclose.

  • Contains 9 Component(s), Includes Credits Recorded On: 05/21/2026

    This three-part series empowers on-site home infusion clinicians to redefine productivity through the lens of quality, safety, and patient-centered care. From understanding performance metrics and refining workflows to learning from real-world case studies, participants will gain practical strategies to enhance efficiency, improve outcomes, and support work-life balance.

    Clinical Edge: Clinical Productivity: What is it and How is it Measured

    This session explores the concept of clinical productivity for on-site home infusion clinicians, focusing on how efficiency and patient outcomes contribute to measurable performance. 

    1. Describe clinical efficiency.
    2. Discuss how clinical efficiency is measured.
    3. Explain why clinical efficiency is crucial in home infusion.

    Clinical Connect: Clinical Effectiveness: Streamlining On-Site Clinical Workflows Without Compromising Quality

    This session explores how home infusion clinicians can deliver care that is both clinically efficient and clinically effective—without compromising safety or quality. Participants will learn about tracking and evaluating current personal workflows and making practical changes to streamline workflows, while upholding high quality of care in an infusion pharmacy environment.

    1. Describe clinical effectiveness.
    2. Discuss practical approaches to improve workflows.
    3. Explain the benefits of keeping quality and safety as the number one priority when developing efficient workflows.

    Clinical Edge: A Case Study: Practical Changes Leading to Improved Time Management for On-Site Clinicians

    This session will take a deep dive into a case study, giving examples of how workflow changes improved efficiencies and work life balance while maintaining patient quality and safety.

    1. Analyze the impact of standardized intake tools on clinician performance and workflow efficiency.
    2. Identify critical insights from standardized patient interviews that influence clinical decision-making.
    3. Assess the role of standardized data in strengthening interoffice communication and on-call team coordination.

    NHIA General CE Information

    Pam McIntyre

    Pam McIntyre

    Consultant

    Expert Infusion Nurse Consulting

    With over 40 years of experience in hospitals, clinics, and home infusion, Pamela McIntyre is a recognized expert in infusion therapy. She offers consulting services to healthcare organizations for developing infusion programs, provides clinical guidance for ambulatory infusion centers, and lends her expertise in infusion-related legal cases through her LLC, Expert Infusion Nurse Consulting. Pamela holds a Masters Degree in Nursing Administration and Leadership and is CRNI, IgCN, OCN, and VA-BC certified. Her unique approach to collaboration among colleagues has significantly enhanced patient care standards and optimized infusion therapy practices for interdisciplinary teams. Reach out to Pamela at [email protected].

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Pam McIntyre has the following relationships to disclose. The content of this presentation will not contain any references to the business lines or products of her employer and will be limited to basic science research. 

    Partner Agreements - Alayacare, Prochant, Lamar Health, Rightway Medical

    Consultant - Eitan Medical, KORU, Scholar Rock

  • Contains 9 Component(s), Includes Credits Recorded On: 07/16/2026

    This three-part series empowers home infusion nurses to recognize and respond to near misses as critical opportunities for learning and system improvement. From identifying LASA medication risks to conducting root cause analysis on real-world events, participants will gain practical tools to enhance safety protocols, prevent harm, and foster a proactive culture of clinical vigilance.

    Clinical Edge: The Missed That Matters: Building a Culture of Learning from Near Misses

    This session explores the concept of near misses in home infusion, highlighting how close calls can reveal hidden risks and opportunities for improvement. Participants will learn why reporting near misses is essential to strengthening safety culture, enhancing care quality, and preventing future harm.

    1. Describe how near-miss events provide insight into various vulnerabilities and opportunities for improvement.
    2. Analyze key contributors to near misses in clinical settings, with emphasis on workflow inefficiencies, human factors, and breakdowns in communication.
    3. Explain the importance of early recognition and reporting of near miss events to strengthen a culture of safety and prevent patient harm.

    Clinical Connect: Double Take: Managing Look-Alike Sound-Alike Drugs for Safer Infusion Care

    This session dives into the risks posed by look-alike sound-alike (LASA) medications in home infusion, where visual and verbal similarities can lead to serious errors. Participants will learn how to identify LASA drugs, implement safeguards, and strengthen safety protocols to protect patients and uphold clinical quality.

    1. Explain how LASA drug errors can occur and the impact they can have on patient care.
    2. Describe examples of LASA drugs and resources available to identify them.
    3. Discuss different strategies to prevent LASA errors in the home infusion setting.

    Clinical Edge: Behind the Mix-Up: A Root Cause Deep Dive into a LASA Near Miss

    This session walks through a real-world case study of a near miss involving a look-alike sound-alike (LASA) drug, using root cause analysis to uncover contributing factors and system vulnerabilities. Participants will learn how to apply structured investigation tools to strengthen safety practices, prevent recurrence, and foster a culture of learning from close calls.

    1. Describe the sequence of events and contributing factors within a LASA near-miss case.
    2. Discuss system and human elements that can lead to LASA errors in the home infusion setting.
    3. Explain process improvements and preventative strategies to reduce recurrence and reinforce safety culture.

    ***Full front matter document will be attached for all 3 sessions

    Aubrey Hersch

    Aubrey Hersch

    Director of Clinical Services

    Soleo Health

    Dr. Aubrey Hersch serves as the Director of Clinical Services at Soleo Health, overseeing clinical education, sterile compounding compliance, accreditation readiness, and quality improvement efforts across 26 pharmacies and over 30 ambulatory infusion centers nationwide. She leads multidisciplinary training programs for pharmacists and nurses, supports field clinicians with clinical and ethical escalations, and ensures ongoing compliance with USP  and  standards. She also acts as a subject matter expert during URAC, ACHC, Board of Pharmacy, and REMS-related audits, and contributes to performance metric development at the executive level.

    Aubrey’s foundation in sterile compounding is extensive. She has overseen cleanroom operations, trained pharmacy managers, and directed internal audits and policy development to align with national compounding standards. Her work on hazardous drug risk assessments using the NIOSH 2024 list and her leadership through pharmacy and state health department inspections underscore her depth of experience in regulatory affairs and operational excellence.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Aubrey Hersch has no relevant financial relationships with ineligible companies to disclose.

    Laura Behnke

    Laura Behnke

    Clinical Pharmacist

    Emerging Health

    Laura Behnke is a clinical pharmacist at Emerging Health in Portland, OR. She started her home infusion career at a hospital based home infusion pharmacy in the Midwest. Laura currently serves as a member on the NHIA Clinical Education Committee where she assists with the annual conference and webinar education.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Laura Behnke has no relevant financial relationships with ineligible companies to disclose.

  • Contains 9 Component(s), Includes Credits Recorded On: 09/17/2026

    This three-part series equips home infusion clinicians with practical strategies to deliver safe, customized parenteral nutrition (PN) care across the patient journey. From assessing referrals and navigating interdisciplinary gaps to tailoring disease-specific plans and safely weaning therapy, participants will strengthen clinical judgment, communication, and continuity in PN management.

    Clinical Edge: Filling the Gaps: Strengthening Assessment During Parenteral Nutrition Start of Care

    A new parenteral nutrition (PN) referral has been received: Has patient been stable for weeks at goal PN or did PN start yesterday with orders for discharge home today? Or, is the order for a home start PN?  Assessing your patient’s PN status upon referral will guide a safe and timely start of care plan. This session will provide clinicians with strategies for assessing upon referral, communicating with prescribing teams to help fill gaps, leading to a customized and safe PN start of care. 

    1. Describe how to assess patient's PN status upon referral.
    2. Discuss strategies for implementing a safe PN start of care.
    3. Explain the significance of communication with the prescribing team during the PN referral process.

    Clinical Connect: Successful Home Parenteral Nutrition Care: Are There Missing Pieces

    Despite experienced home infusion teams implementing custom parenteral nutrition (PN) patient care plans, pieces can be missing for therapy excellence: partnership and communication among infusion provider and prescriber teams can be tricky to navigate; assessing PN needs for various underlying disease states can prove to be complex. This session will explore techniques for enhancing partnerships among PN care teams and will examine customizing assessments for various PN patient disease states. Case examples will showcase strategies to help fill in missing pieces for strengthening PN patient care. 

    1. Describe partnering among care teams for managing PN patients. 
    2. Discuss common PN patient disease states and assessment considerations.
    3. Identify strategies for partnering and customizing care plans to strengthen PN patient care.

    Clinical Edge: Filling Gaps: Practical Methods for Weaning Patients from Parenteral Nutrition

    Were orders received to “wean PN, or stop PN” without detail or direction from the prescriber?  Are you wondering if your patient is truly ready to wean from PN, and if so, how to wean safely? This session will provide actionable strategies for safely weaning patients from PN.

    1. Describe how to identify when weaning PN is appropriate.
    2. Discuss strategies for safely weaning PN.
    3. Explain monitoring and minimizing complication risk during PN weaning.

    NHIA General CE Information

    Lisa Kinder, RD, CNSC

    Lisa Kinder, RD, CNSC

    Clinical Program Manager

    Optum Infusion Pharmacy

    Lisa Kinder is a registered dietitian, maintains certification as a nutrition support clinician, and has worked in the home infusion setting since 2004. She is a clinical nutrition program manager at Optum Infusion Pharmacy. Her current role focuses on training and education programs for clinicians providing home parenteral nutrition. She is passionate in the areas of safe parenteral nutrition initiation in the home setting and the prevention of refeeding syndrome. Lisa has co-authored publications including abstracts, continuing education articles, a white paper, and has presented posters and educational sessions at national conferences including ASPEN and NHIA. She serves on NHIA’s Education Committee. Lisa received UnitedHealth Group’s Sages of Clinical Services Award in 2019, is a member of the home nutrition support team that was honored with ASPEN’s Clinical Nutrition Team of Distinction Award in 2022, received ASPEN’s HPEN Trailblazer Award in 2023 and became a NHIA Fellow in 2025.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Lisa Kinder has no relevant financial relationships with ineligible companies to disclose.

  • Contains 9 Component(s), Includes Credits Includes Multiple Live Events. The next is on 11/17/2026 at 12:00 PM (EST) Recorded On: 11/19/2026

    This three-part series invites participants to explore their communication habits, flex their style for stronger collaboration and customer impact, and deliver appreciation in ways that truly resonate. Through self-assessment, real-world reflection, and practical tools, attendees will strengthen empathy, clarity, and connection—fueling trust, morale, and team performance.

    Clinical Edge/Nurse Bytes: Self-Evaluation: What is your Communication Style

    This session uncovers the habits, strengths, and blind spots that shape how you connect with others. This rapid-fire self-assessment helps you identify your dominant communication style, explore how it impacts collaboration, and discover strategies to flex your approach for stronger relationships and team dynamics.

    1. Identify your primary communication style and recognize how it influences workplace interactions.
    2. Explore strategies to adapt communication styles for more effective engagement across diverse teams.

    Clinical Connect/Nurse Necessities: Communication Styles: What Are They & How Does It Impact Customer Service

    Your communication style doesn’t just shape conversations—it drives customer experience. In this 30-minute session, participants will explore four core communication styles, uncover how each influences customer interactions, and learn how to flex their approach to meet diverse needs. Through real-world examples and guided reflection, attendees will gain practical tools to elevate empathy, clarity, and connection in every customer touchpoint.

    1. Differentiate between key communication styles and their impact on customer perception and satisfaction.
    2. Analyze how mismatched communication styles can lead to service breakdowns or missed opportunities.
    3. Apply adaptive communication strategies to enhance empathy, responsiveness, and service excellence.

    Clinical Edge/Nurse Bytes: Challenge: Improving Your Serve: 5 Languages of Appreciation

    This session level sup your impact. In this fast-paced 15-minute challenge, participants will explore the 5 Languages of Appreciation and how they shape meaningful recognition in the workplace. Through quick reflection and practical examples, attendees will learn how to “serve” appreciation in ways that resonate—boosting morale, trust, and team connection. 

    1. Identify the five languages of appreciation and their relevance to workplace communication and engagement.
    2. Apply appreciation strategies that align with individual preferences to strengthen relationships and team culture.

    ***Full front matter document will be attached for all 3 sessions

    Michelle Mais-Smith

    Michelle Mais-Smith

    Nurse Manager

    Coram CVS Specialty Infusion

    Michelle Mais-Smith, MSN, RN, CRNI, is the Nursing Manager for Coram/CVS Specialty Home Infusion, overseeing nursing operations across Illinois and Indiana. With more than 12 years of experience in home infusion and over 7 years in management, Michelle is recognized for her leadership in advancing quality patient care and supporting multidisciplinary teams. She is CRNI certified and passionate about leveraging her expertise to improve both patient outcomes and nursing practice.

    Outside of work, Michelle enjoys traveling and cherishing time with her husband of 25 years, their four children, and close friends.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Michelle Mais-Smith has no relevant financial relationships with ineligible companies to disclose.

    Elena Stoyanova, MSN, RN, CRNI

    Elena Stoyanova, MSN, RN, CRNI

    Director of Nursing Services & Clinical Education

    Nutrishare LLC

    Elena Stoyanova, MSN, RN, CRNI, is the Director of Nursing Services and Clinical Education at Nutrishare. She holds a Master of Science in Healthcare Quality Management from MidAmerica Nazarene University and a Bachelor of Science in Nursing from the University of Missouri–Kansas City, with undergraduate studies in biological science at Mount Holyoke College.

    Elena has more than 13 years of nursing experience spanning critical care, nursing education, and home infusion, with her current work focused on home parenteral nutrition (HPN). In her role at Nutrishare, she leads national nursing strategy and clinical education initiatives, supports quality improvement efforts, and contributes to the development of clinical policies aligned with industry standards. Her work includes participation in interdisciplinary infection prevention programs with a strong emphasis on patient safety and the reduction of central line–associated bloodstream infections (CLABSI), while promoting consistent, high-quality nursing practice across home infusion settings.

    Elena is active in professional organizations including ASPEN, NHIA, and INS, and contributes to the field through national presentations and educational initiatives. Her recent work includes the development of educational tools focused on central line complication recognition and escalation, designed to empower patients and caregivers to make informed decisions in the home setting. In recognition of her leadership and contributions to nutrition support nursing, she received the ASPEN New Practitioner Award in Nursing in 2025. She continues to advance nursing practice through program development efforts such as the Nutrishare Nursing Network and ongoing scholarly work focused on patient education, interdisciplinary collaboration, and complication prevention.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Elena Stoyanova has no relevant financial relationships with ineligible companies to disclose.